Ajanta Out-Licenses Product to Taiwan Firm (India)
This article was originally published in PharmAsia News
Executive Summary
India-based drug maker Ajanta is currently bucking the market trend of in-licensing foreign pharmaceuticals for production in India. Instead, Ajanta is out-licensing its anti-scar drug Vanzia to Taiwan-based Orient Europharma. Under the contract the drug will be marketed by Orient in Singapore, Macau, Hong Kong, and Malaysia, as well as Taiwan. Ajanta has also agreed to sell manufacturing technology to the drug in exchange for an up-front cash payout, and further revenue sharing. (Click here for more